A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus

被引:330
作者
Dittmer, D
Lagunoff, M
Renne, R
Staskus, K
Haase, A
Ganem, D
机构
[1] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA
[2] Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA
[3] Univ Minnesota, Dept Microbiol, Minneapolis, MN 55455 USA
关键词
D O I
10.1128/JVI.72.10.8309-8315.1998
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) is closely associated with Kaposi's sarcoma (KS) and primary effusion lymphoma, with viral genomes present in a latent state in the majority of tumor cells. Here we describe a cluster of latently expressed viral genes whose mRNAs are generated from a common promoter. Two mRNAs in this region encode the latency-associated nuclear antigen, the product of open reading frame 73 (ORF73). The larger RNA, of 5.8 kb, is an unspliced transcript that includes ORF72 and -71 at its 3' end; it initiates at nucleotides (nt) 127880 to 127886 from a promoter lacking recognizable TATA elements. A less abundant mRNA, of 5.4 kb, is a variant of this transcript, in which 336 nt of 5' noncoding information has been removed by RNA splicing. A third, more abundant RNA is generated from the same promoter region via splicing from the common splice donor at nt 127813 to an acceptor 5' to ORF72; this transcript is the presumed mRNA for ORF72, which encodes the viral cyclin D homolog. All three RNAs are 3' coterminal. In situ hybridization analysis with probes that can detect all three transcripts shows that the RNAs are detectable in a large fraction of BCBL-1 cells prior to lytic induction and in > 70% of KS spindle cells in primary KS tumors. This confirms that these transcripts are indeed latent RNAs and suggests a role for their products in viral persistence and/or KSHV-associated proliferation.
引用
收藏
页码:8309 / 8315
页数:7
相关论文
共 38 条
[11]   The prevalence of serum antibody to human herpesvirus 8 (Kaposi sarcoma-associated herpesvirus) among HIV-seropositive and high-risk HIV-seronegative women [J].
Kedes, DH ;
Ganem, D ;
Ameli, N ;
Bacchetti, P ;
Greenblatt, R .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1997, 277 (06) :478-481
[12]   The seroepidemiology of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus): Distribution of infection in KS risk groups and evidence for sexual transmission [J].
Kedes, DH ;
Operskalski, E ;
Busch, M ;
Kohn, R ;
Flood, J ;
Ganem, D .
NATURE MEDICINE, 1996, 2 (08) :918-924
[13]  
Kellam P, 1997, J Hum Virol, V1, P19
[14]  
KIRSHNER J, UNPUB
[15]   EPSTEIN-BARR-VIRUS STRATEGY IN NORMAL AND NEOPLASTIC B-CELLS [J].
KLEIN, G .
CELL, 1994, 77 (06) :791-793
[17]   The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) [J].
Lagunoff, M ;
Ganem, D .
VIROLOGY, 1997, 236 (01) :147-154
[18]   Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin [J].
Li, MT ;
Lee, HR ;
Yoon, DW ;
Albrecht, JC ;
Fleckenstein, B ;
Neipel, F ;
Jung, JU .
JOURNAL OF VIROLOGY, 1997, 71 (03) :1984-1991
[19]   Human herpesvirus-8/Kaposi's sarcoma-associated herpesvirus is a new transmissible virus that infects B cells [J].
Mesri, EA ;
Cesarman, E ;
Arvanitakis, L ;
Rafii, S ;
Moore, MAS ;
Posnett, DN ;
Knowles, DM ;
Asch, AS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 183 (05) :2385-2390
[20]   Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection [J].
Miller, G ;
Rigsby, MO ;
Heston, L ;
Grogan, E ;
Sun, R ;
Metroka, C ;
Levy, JA ;
Gao, SJ ;
Chang, Y ;
Moore, P .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (20) :1292-1297